Reports

One EV Stock to Consider and One to Avoid

Electric vehicle stocks have witnessed a deep correction in the last few quarters, but the long-term potential for EV makers remains attractive due to increased adoption in many countries. It is believed that by 2030, EVs will represent more than 60% of vehicles sold globally. In other words, Global EV penetration is expected to increase from 14.7 in 2022 to 44.8% by 2030.  

Anyone optimistic about the EV revolution and looking to add to their EV maker positions would do well to be cautious. Amid increasing competition in the space, certain EV companies could struggle to recover from headwinds like overvaluation, supply chain concerns, and inflation. The wrong EV stock could prove to be like portfolio poison. In the following article, we’ll take an in-depth look at one stock to avoid and one to consider ahead of a potentially rocky turnaround for EV makers. 

Li Auto Inc (LI)

For Q3 2022, Li Auto delivered 26,524 vehicles. Despite inflation headwinds, Li reported an operating cash flow of $71.4 million. The company closed Q3 2022 with a solid cash position of $7.85 billion,  providing ample financial flexibility for aggressive retail expansion this year. All signs point to an acceleration in vehicle deliveries through 2023.  

[stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”LI” range=”6mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”]

Lucid Group Inc (LCID)

Lucid shares are down more than 80% since the November 2021 ATH, and there’s little to indicate that the stock will rebound. The company produced only 7,180 vehicles in 2022 and managed to deliver only 4,369 of them. Lucid continues to be unprofitable, and analysts are expecting that to continue into 2023.

[stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”LCID” range=”6mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”]

[stock_market_widget type=”comparison” template=”cards” color=”#5679FF” assets=”LI,LCID” fields=”name,change_abs,change_pct,volume,dividend_yield,eps,pe_ratio,shares_outstanding,market_cap,chart” links=”{‘LI’:{},’LCID’:{}}” display_currency_symbol=”true” api=”yf” chart_range=”1mo” chart_interval=”1d”]

Three Value Stocks to Buy Now

The past year produced a performance chasm between value and growth equities, with value recapturing the lead following a strong run for growth in recent years. As interest rates rose rapidly in 2022, with the Fed funds rate now around 4.3%, we saw downward pressure on higher-valuation assets, including growth stocks. Many investors gravitated towards more defensive value sectors. A U.S. large-cap value index fell nearly 8% on a total return basis while its growth-style counterpart dropped 29%.

Value will likely continue to outperform growth in the near term as the Fed continues down its rate-hiking path. Here are three value stocks to consider in the first half of 2023.  

CF Industries Holdings, Inc. (CF)

CF Industries is a major distributor of North American nitrogen fertilizer products. Disruption in fertilizer supplies caused by the war in Ukraine has sent fertilizer prices soaring to record highs.   CF is generating plenty of cash flow to achieve a net cash position, buy back an estimated $1.5 billion in stock in 2023, explore targeted acquisitions and invest in clean nitrogen projects.

[stock_market_widget type=”accordion” template=”info” color=”#5679FF” assets=”CF” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

NVR, Inc. (NVR)

NVR is one of the top five major U.S. homebuilders. Rising mortgage rates have weighed on the U.S. housing market. However, as one of the highest-quality homebuilders in the group,  the stock has a history of outperforming peers during difficult periods in the housing market cycle.

[stock_market_widget type=”accordion” template=”info” color=”#5679FF” assets=”NVR” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Warner Bros. Discovery, Inc. (WBD)

Warner Bros. Discovery is a leading global media company, TV and movie studios.   Management’s top priority in the next six months is relaunching a consolidated streaming service with live sports content as a central part of the company’s portfolio, including its rights to March Madness, NHL, MLB playoffs, and the NBA.

[stock_market_widget type=”accordion” template=”info” color=”#5679FF” assets=”WBD” start_expanded=”true” display_currency_symbol=”true” api=”yf”]

Three Stocks to Watch for the Week of January 16th

Stocks rose for the second consecutive week of 2023, fueling hope that the worst was left behind in 2022. The Dow finished the week 2% higher, the S&P 500 added 2.7%, and the Nasdaq stacked on 4.8%.  

In just nine months, interest rates have climbed from net zero to a target range of 4.25% to 4.5%. However, recent signs of cooling inflation have added to expectations that the Fed may not raise rates much further. With a slowdown in the pace of consumer price inflation in December reported last week, expectations are growing that the central bank could raise interest rates by just 0.25 percentage points next month, a step down from the most recent 0.5 percentage point rate increase.

A handful of major banks kicked off earnings season Friday with mixed results. According to FactSet, analysts forecast that fourth-quarter earnings for the S&P 500 companies fell by an average of 3.9%, which would mark the first year-over-year decline since the third quarter of 2020. Earnings season continues in the holiday-shortened week ahead, with more reports due from big banks, including Goldman Sachs, Morgan Stanley, and Charles Schwab, among others.  

Markets will be closed on Monday in observance of Martin Luther King, Jr. Day, but the short week will be packed with points of interest for market participants. On Wednesday, we’ll get a critical update on consumer spending during the holiday season with the Census Bureau’s December retail sales report. Also, on Wednesday, the Bureau of Labor and Statistics will release December’s Produce Price Index (PPI) reading, which tracks inflation from the standpoint of goods manufacturers and wholesalers.  

Throughout 2022, established automakers like Ford, GM, and Mercedes unveiled plans for dozens of new electric vehicles. Mass production of most of these vehicles will kick into gear starting in 2023 and 2024. Our first of three stock recommendations for the week ahead is a small cap with extreme growth potential over the next few years on the black of upcoming E.V. production.   

By 2029, electric vehicles could account for a third of the North American market and about 26% of vehicles produced worldwide, according to AutoForecast Solutions. Lithium Americas Corp (LAC) is one company hoping to ride the wave of anticipated global E.V. demand. Launched in 2007, the Canada-based firm searches for lithium deposits in the U.S. and Argentina. While the company is still a pre-revenue concern, its pipeline is brimming with potential, including one project set to enter production stages this year.

The company has full ownership of two development-stage operations in Argentina. One of which is approaching initial production, expected to come later this year. The timeline has been disrupted on LAC’s U.S. project –The Thacker Pass, Nevada lithium mine – due to ongoing legal and regulatory discrepancies. However,  a U.S. judge said on Thursday she would rule “in the next couple of months” on whether former President Donald Trump erred in 2021 when he approved the company’s right to begin mining the U.S.’s largest-known lithium resource. It seems likely that the outcome of the case will be positive for LAC, considering Washington’s push to boost domestic production of metals crucial to the green energy transition and wean the country off of Chinese supplies.  

The high-growth -potential small-cap has been gaining the attention of the pros on Wall Street. “We believe 2023 could be an eventful year as there could be a number of key announcements on growth projects and Argentina divesture, which could be catalysts for the share price,” explained HSBC analyst Santhosh Seshadri. To this end, Seshadri recently initiated coverage of LAC with a Buy rating, backed by a $36 price target.

Most analysts agree with Seshadri’s thesis. LAC claims a Strong Buy consensus rating, based on 13 Buys versus 1 Hold and no Sell ratings. At $37, the average price target makes room for 12-month gains of 79%.

A logical move in times like these is dividend stocks, which pay you just to hold them. Dividend-paying companies regularly reward investors directly with a portion of the cash flow. The most desirable dividend stocks have a history of raising payouts over time as the company’s profits grow.  

Pioneer Natural Resources Company (PXD) has long viewed sustainability as a balance of economic growth, environmental stewardship, and social responsibility. Its emphasis is on developing natural resources in a manner that protects surrounding communities and preserves the environment.

In the wake of the pandemic, when energy prices were, cheap Pioneer struck an almost perfectly timed agreement to buy fellow Permian Basin producer Parsley Energy for $4.5 billion. If you’re wondering how the company managed to finance that transaction, the answer lies in the fact that it was an all-stock deal that ensured Pioneer didn’t have a new giant debt load hanging over its head. The fact that Parsley operated primarily in the same region of West Texas, where Pioneer had both expertise and existing staff, has paid off over time.   

That deal was a coup for Pioneer shareholders, built on the fact it was large and well-capitalized at a time when stressed and debt-reliant shale plays were looking for a white knight. On top of that acquisition, PXD also boosted its dividend by 25% at the start of the year as further evidence of its strong balance sheet.

Investors can look forward to upcoming tailwinds, including Pioneer’s recently announced partnership with the world’s largest renewable energy producer, NextEraEnergy (NEE), to develop a 140-megawatt wind generation facility on Pioneer-owned land. The project will supply the company’s Permian Basin operations with low-cost, renewable power and is expected to be operational next year.  

In the third quarter, revenue was up 22% YOY to $6.09 billion, smashing the consensus estimate of 4.57 billion. The company reported earnings of $7.48 per share, beating consensus expectations of $7.27 per share. So far, in 2022, the company has rewarded its investors handsomely with $20.73 per share through its generous 10.78% cash dividend. Chief Executive Officer Scott D. Sheffield stated, “Pioneer continues to execute on our investment framework that provides best-in-class capital returns to shareholders. This framework is expected to result in $7.5 billion of cash flow being returned to shareholders during 2022, including $26 per share in dividends and continued opportunistic share repurchases.”

Even after gaining 33% over the past year, Pioneer shares likely still have valuation upside in addition to their tremendous dividend income potential.   

Booz Allen Hamilton (BAH) is one of the world’s largest cybersecurity solutions providers. Specializing in marketing cybersecurity products that are produced by other companies, nearly every U.S. federal, intelligence and defense agency uses its services. In other words, Booz Allen is poised to scoop up a significant portion of the whopping 15.6 billion that the U.S. is expected to spend on cybersecurity in 2023.

For its fiscal 2023 second quarter, which ended September 30, revenue surged 9.16% year over year to $2.3 billion, while its net income jumped an impressive 10.4% to $170.93 million. Booz Allen reported quarterly earnings of $1.25 per share, exceeding Wall Street expectations of $1.13 per share. The company raised its full-year EPS view to $4.24-$4.50 from $4.15 – $4.45. Wall Street expects $4.88 EPS for the entire year, indicating a reasonable forward P/E of 24 times.  

Cowen analyst Cai von Rumohr recently raised the firm’s price target on BAH to $123 from $109 after hosting the company at the firm’s London Industrials & Renewables Summit and coming away with a favorable outlook, driven by continued demand tailwinds and an easing labor market. The current consensus recommendation is to Buy BAH. A median price target of $115 implies an 11% upside. The stock comes along with a 1.66% dividend yield.

Three Stocks to Avoid For Now

Seeking out great stocks to buy is important, but many would say it’s even more essential to know which stocks to steer clear of. A losing stock can eat away at your precious long-term returns. So, determining which stocks to trim or eliminate is essential for proper portfolio maintenance.  

Even the best gardens need pruning, and our team has spotted a few stocks that seem like prime candidates for selling or avoiding. Continue reading to find out which three stocks our team is staying away from this week. 

According to CME data, investors expect to see short-term interest rates jump to a range of 5% to 5.25% before pausing, pointing to an increasingly likely recession in the wings. According to The Economist, in six of the past seven rate hiking cycles where rates increased this rapidly, a recession formed within two years.  

One stock that has been especially vulnerable during recessions that may surprise you is aircraft maker Boeing (BA). The share price has dropped an average of 40% in the past five recessions, underperforming every other S&P 500 stock by the same metric. Shares of Boeing sank 56% in the recession that began in 2020, 43% in the one that started in 2007, and 47% in the 2001 recession. 

Despite its role as a leader in commercial airplanes, demand seems to evaporate for Boeing products during recessions, along with its typically healthy backlog and direction for the stock. That presents a real hazard for anyone eyeing BA after plunging 37% so far this year. If a recession is forming, this could be just the beginning of Boeing’s losing streak.  

At their September lows, Boeing shares were approaching levels comparable to the early days of the pandemic.   If the economy is indeed heading toward an extended slowdown, it could take years for Boeing shares to reach previous heights. Given all of the uncertainties combined with the lack of any significant positive catalyst for the company heading into 2023, we’re sticking to the sidelines on the stock.  

Over the past two years, the dramatic shift from brick-and-mortar shopping to e-commerce has been a tremendous obstacle for investors in malls and shopping centers. The demise of cornerstones like Sears and JCPenny hastened the decline as shopping malls are now left without anchor tenants.   Recent data suggests that 25% of America’s 1,000 malls will be closed in the next 3-5 years.  

Leading shopping mall REIT Simon Property (SPG) is struggling to pivot amid the inexorable decline of its core asset group. The REIT has been aggressive in diversifying into outlets and foreign real estate, which may help to hedge against increasingly substantial losses from their shopping mall category. But given current inflation and the possibility of an economic slowdown, both shoppers and retailers may be in a tight spot this holiday season which will inevitably weigh heavily on SPG.  

Investors choose REIT stocks because of their income-producing abilities and yields. The fact that SPG is concentrated in brick-and-mortar retail is tangential to its income feature. Anyone looking for the reliable income that real estate and mortgage investments can bring would be wise to steer clear of Simon Property for now. 

Food delivery leader and pandemic darling DoorDash (DASH) was one of the big winners in the shift to stay-at-home culture. Between 2019 and 2021, DASH revenue increased by 451% from $885 million to $4.88 billion. But once the economic reopening was complete, Wall Street’s enthusiasm over the stock sharply halted. Since hitting its peak in November of last year, the stock has plunged more than 75%. Now that the tide has washed out, investors are left to access what’s left, searching for an answer to the looming question – is profitability in the cards for DoorDash?

DoorDash has never generated a profit, with the exception of the second quarter of 2020, where it made a profit of $23 million. “It took a global pandemic to drive the firm’s one-quarter profitability. The firm has not been profitable since, and we think it may never be,” said David Trainer, the CEO and founder of New Constructs.

The company reported third-quarter revenue and EBITDA of 4% and $29M above consensus expectations, but  DASH’s EPS is estimated to remain negative in 2022 and 2023. The company is expecting $49 to $51 billion in gross order volume in 2022, implying a modest 14% increase from $41.9 billion last year. However, that’s not enough to justify DASH’s lofty valuation. Currently, the stock trades at a price-to-sales multiple of 4.6, expensive compared to top competitors like Uber Technologies (UBER), which trades at a price-to-sales multiple of 2.1 – half that of DASH.

One Fintech Stock to Buy and One to Avoid Like the Plague

Amid rising interest rates and a drastic rotation out of technology, fintech stocks have taken a beating this year, vastly underperforming the overall market. Global X FinTech ETF (FINX), which tracks an index of up to 100 fintech stocks, has plunged 41% over the past 12 months versus the S&P 500’s loss of 15%. Many fintech names are also feeling the pressure from the recent plunge in digital currency prices resulting from the FTX bankruptcy. Meanwhile, competition in the space is intensifying as a wave of fintech startups aim to draw in merchants.  

Nevertheless, the shift in consumer spending habits to online and mobile platforms is undeniable. Expansion of the adoption of contactless payment and the growing popularity of “buy now, pay later” transactions should serve as significant tailwinds for the strong names in the industry. But not all fintech companies will stay in the race.  

With a potential rebound for fintech stocks on the horizon in 2023, many investors are considering stocks from the group that have had their prices recently slashed. However, not all tickers from the space are equal. Some companies are likely to recover more robustly than others, while others may have further to fall. In this article, we’ll take a look at two firms from the fintech space. One that has several positive qualities that are likely to give it steam for a healthy rebound; the other – not so much.  

StoneCo Ltd. (STNE) provides back-office software, loans, and other financial services to small and medium-sized businesses with a focus on reinvesting the cash it generates to acquire or build new financial products for its customer base. Since early 2019, the company has grown the number of small and medium business clients by 3x, revenue by 2.3x, and net income by 2.2×. 

StoneCo has developed a range of payment solutions utilized by e-commerce for businesses and merchants all over Latin America. StoneCo reported about $390 million in revenue and earnings in the third quarter. Small and medium-sized businesses using the platform surpassed 2.3 million, and total payment volume in the quarter also grew to close to $14 billion.

StoneCo stock is down close to 54% this year on news of rising interest rates, macroeconomic risks in Brazil, and some operational blunders. But base interest rates in Brazil seem to have peaked. A potential decline in the second half of 2023 is expected as Brazil’s inflation normalizes, reducing the margin pressure from rising financial expenses. Meanwhile, StoneCo’s revenue growth should benefit from increasing digitization of payments, higher take rates, and elevated growth in banking and software. STNE stock currently trades at roughly 1.4 times projected forward revenue and 33 times forward earnings, which seems fair for a disruptive, fast-growing company in a developing market.  

Some prominent institutional investors have recently taken a shine to STNE. At the end of the third quarter, Berkshire Hathaway disclosed a new $110 million position in the company. Cathie Wood’s Ark Innovation fintech exchange-traded fund (ARKF) also owns roughly 2.55 million shares of the payments company valued at more than $26.5 million. STNE has a Hold rating from the pros who cover it and a median target price of $12.41, representing a 28% increase from Friday’s closing price.  

While a winning fintech stock could boost your portfolio significantly, the wrong fintech stock could be detrimental to your precious long-term returns. That’s why avoiding tickers from the group that seem especially vulnerable is critical. One stock we’re avoiding is Upstart Holdings (UPST). 

Upstart’s management provided less than inspiring Q4 guidance during the company’s disappointing third-quarter earnings call, sparking yet another sell-off for the stock. UPST share price is down more than 95% from its October 2021 ATH, and it may have more to go as bank partners tighten their fists.  

Amid aggressive shifts in monetary policy, institutional lenders are less willing to fund Upstart’s loans than ever. It makes sense for backers to be so cautious in the current macroeconomic environment. Rising interest rates will continue to pressure consumers leading to more defaults. Upstart is especially vulnerable as its AI models have yet to be tested during a significant down period in the credit cycle.  

Making matters worse, Upstart more than doubled the amount of loans it funded in Q2 2022 in just a single quarter. The company reported $600 million in loans on its own balance sheet, up from $250 million in the previous quarter, severely exposing its balance sheet to credit risk at a terrible time. This contributed to Upstart’s third-quarter revenue miss and management’s decision to lower Q4 guidance. 

Management sees Q4 revenue in the range of $125 million to $145 million. That implies revenue growth of roughly 18%, representing a sharp deceleration from the 252% revenue growth UPST delivered in Q4 2021. With growth momentum slowing while competition in the space is simultaneously growing, UPST is one fintech stock to stay away from for now. The current consensus recommendation is to Sell Upstart. A median price target of $14 represents a 20% decrease from Friday’s closing price.   

Three Network Security Stocks to Watch in 2023

One of the biggest threats to corporate America is ransomware. The growing possibility of losing access to essential or confidential digital property is a nightmarish scenario for executives, as the financial consequences can be enormous.  

But it’s not just major companies that are at risk. We are all threatened with the loss of personal data security as hackers continue to develop new ways to exploit networks, software, and the array of evolving technology services. As the world advances to become more digitized, so too do its threats.

According to Research and Markets, the global network security market size reached a valuation of $4.68 billion in 2021. Experts project that by 2027, the segment will command a valuation of $16.6 billion, representing a CAGR of 23.5% from 2023 estimates.

Online security is a young, quickly evolving industry. Competition is heavy in the space, and demand continues to grow faster in volume and complexity. Not all companies from the burgeoning subsector are set to last. In this article, our team examines three attractive tickers set to benefit as the demand for protection from cyber abuse continues to grow.

Palo Alto Network Inc. (PANW) has been helping customers stay ahead of quickly evolving cybersecurity threats for over a decade. For ten years straight, the company has been named a market leader in network firewalls by leading research and advisory company Gartner. In fact, it achieved the highest position for ability to execute and the furthest position for completeness of vision in Gartner’s Magic Quadrant for Network Firewalls for 2021. Still, they haven’t been letting the recognition go to their head. Over the past few years, Palo Alto has aggressively expanded its portfolio with significant investments and acquisitions.    

The groundbreaking acquisition of Bridgecrew, a developer-first cloud security company, enabled Palo Alto’s Prisma Cloud to become the first cloud security platform to deliver security across the entire lifecycle of an application, from the building stage to deployment to run. This is the most recent in a string of additions to its NGS (next-generation security) services portfolio.

In fiscal 2021, Palo Alto’s NGS services generated $1.18 billion in annual recurring revenue (ARR), representing roughly 28% of its top line and surpassing its prior ARR guidance of $1.15 billion. That segment’s accelerating growth complemented the stable growth of its on-site appliances and services, and its total revenue increased by 25% for the full year. 

Palo Alto serves more than 85,000 customers today, compared to about 9,000 customers nine years ago. The company expects its revenue to rise 24%-25% in fiscal 2022, and its stock trades at about thirteen times that forecast. 

The consensus among 37 analysts offering recommendations for the stock is to Buy PANW. There are currently 32 Buy ratings, 2 Hold ratings, and no Sell ratings. A median price target of $217 represents a 54% upside from the current price. 

The undisputed global leader when it comes to identity security, CyberArk (CYBR), has been gaining attention on Wall Street. The stock is up 26% over the past six months and could continue to gain heading into 2023. Regardless of any short-term earnings volatility, the potential for long-term, steady growth is too great to ignore.  

CyberArk’s innovations occur across its self-hosted solutions and expanding SaaS portfolio of privileged access management, secrets management, and cloud privilege security offerings, helping its customers enable “Zero Trust” by enforcing least privilege. Under the framework of its Zero Trust approach, its teams can focus on identifying, isolating, and stopping threats from compromising identities and gaining privilege before they can do harm.

The Israel-based company was recently named a leader in the Gartner Magic Quadrant for Privileged Access Management for 2021. It was positioned both highest in the ability to execute and furthest in the completeness of vision for the fourth time in a row. It comes as no surprise the business has been attracting customers to its subscription-based services, which means tremendously reliable cash flow, a good sign for anyone eyeing the small-cap.  

For its third quarter, CyberArk reported a 133% growth acceleration from the previous year’s quarter of the subscription portion of its annual recurring revenue (ARR) to $255 million. Total ARR came in at $465 million, with growth Accelerating to 48%. Management also increased the full-year 2022 ARR Guidance Range to  $589-$601 million, up from a prior estimate of $583.5-$598.5 million.

According to Mordor Intelligence, the application delivery controller market is expected to reach a valuation of $3.78 billion by 2026, representing a CAGR of 9.63%. One of the companies set to benefit most from the trend is A10 Networks (ATEN). Specialists, when it comes to the manufacturing of application delivery controllers, A10 leverages artificial intelligence protocols to provide automated protection against distributed denial-of-service (DDoS) attacks, which are increasing in relevance by the day.  

Widening profit margins surfaced in the most recent quarterly results as earnings expanded faster than revenues. Third-quarter earnings came in at $0.20 per share, surpassing the consensus estimate of $0.18. Revenues were also upbeat at $72.1 million, representing a 10% increase from the same period last year and exceeding analyst expectations of $$71.02 million.

A10 is consistently achieving revenue and EPS targets despite a variety of macro headwinds in all regions. This demonstrates robust demand for our proprietary security-led solutions, disciplined execution, and a focus on diversification that drives sustainability. We have positioned our business to avoid concentration in any single geography, any specific customer type, or any isolated product offering, and this diversification enables consistent execution despite economic, supply chain, and geopolitical challenges. Customer-centric technical innovation, global commercial execution, and focus on driving the business model are bolstering our sustainability and driving continued success,” said Dhrupad Trivedi, President and CEO of A10 Networks.

The drastic earnings growth indicates the business is going from strength to strength. A trend that investors hope will continue well into the future. Management reiterated its full-year top-line growth target of 10 – 12% and expanded EBITDA in the range of 26 – 28% of revenue. A10 Networks certainly ticks a few boxes on the list of desirable qualities and seems well worth watching.

Three Stocks to Watch for the Week of January 9th

Stocks rose sharply to close out the week, following an encouraging jobs report as investors consider its possible implications on future Fed moves. Friday’s rally left the major indexes (which started the session negative for the week) with a weekly gain to open the new year. The S&P 500 and the Nasdaq snapped three-week losing streaks, with gains of 1.5% and 1%, respectively. Meanwhile, the Dow stacked on around 1.5%.

January’s stock market performance has historically been a reliable indicator of what could be in store for the rest of the year. In fact, according to S&P Dow Jones Indices, 71% of the time since 1929, the S&P 500 has posted a positive return for the year after moving higher in January or, conversely, has gone on to post an annual loss when the market has declined in January.

As major banks prepare to kick off earnings season this week, analysts have been dialing back their expectations. Over the past three months, analysts reduced their Q4 EPS estimates for companies in the S&P 500 by an average of 6.5%, according to FactSet. That figure far exceeds the 3.8% average reduction seen before earnings seasons over the past 20 years. JPMorgan Chase, Bank of America, Wells Fargo, Citigroup, and BlackRock are scheduled to report on Friday. Other major companies, including Taiwan Semiconductor Manufacturing Company, UnitedHealth Group, and Delta Air Lines, will also report quarterly earnings next week. 

A logical move in uncertain times is dividend stocks, which pay you to hold them. Dividend-paying companies regularly reward investors directly with a portion of the cash flow. The most desirable dividend stocks have a history of raising payouts over time as the company’s profits grow. Our first of three stock recommendations for the week ahead is a ticker with solid upside potential and tremendous dividend income potential.   

Pioneer Natural Resources Company (PXD) has long viewed sustainability as a balance of economic growth, environmental stewardship, and social responsibility. Its emphasis is on developing natural resources in a manner that protects surrounding communities and preserves the environment.

In the wake of the pandemic, when energy prices were, cheap PXD struck an almost perfectly timed agreement to buy fellow Permian Basin producer Parsley Energy for $4.5 billion. If you’re wondering how PXD managed to finance that transaction, the answer lies in the fact that it was an all-stock deal that ensured Pioneer didn’t have a new giant debt load hanging over its head. The fact that Parsley operated primarily in the same region of West Texas, where Pioneer had both expertise and existing staff, has paid off over time.   

That deal was a coup for Pioneer shareholders, built on the fact it was large and well-capitalized at a time when stressed and debt-reliant shale plays were looking for a white knight. On top of that acquisition, PXD also boosted its dividend by 25% at the start of the year as further evidence of its strong balance sheet.

Investors can look forward to upcoming tailwinds, including Pioneer’s recently announced partnership with the world’s largest renewable energy producer, NextEraEnergy (NEE), to develop a 140-megawatt wind generation facility on Pioneer-owned land. The project will supply the company’s Permian Basin operations with low-cost, renewable power and is expected to be operational next year.  

In the third quarter, revenue was up 22% YOY to $6.09 billion, smashing the consensus estimate of 4.57 billion. The company reported earnings of $7.48 per share, beating consensus expectations of $7.27 per share. In 2022, the company has rewarded its investors handsomely with $20.73 per share through its generous 10.78% cash dividend. Chief Executive Officer Scott D. Sheffield stated, “Pioneer continues to execute on our investment framework that provides best-in-class capital returns to shareholders. This framework is expected to result in $7.5 billion of cash flow being returned to shareholders during 2022, including $26 per share in dividends and continued opportunistic share repurchases.”

Even after gaining 33% over the past year, Pioneer shares likely still have valuation upside in addition to their tremendous dividend income potential.   

Taiwan Semiconductor (TSM), also known as TSMC, is at the top of the list when it comes to the semiconductor manufacturing group. The company makes chips for the likes of AMD (AMD), Nvidia (NVDA), and Qualcomm (QCOM), and it’s a key chip supplier to Apple (AAPL).  

After hitting a two-year low due to a sharp slowdown in global chip demand, TSM’s share price jumped when Berkshire disclosed its more than $4.1 billion position in the stock. Still down more than 40% from its January 2021 peak, anyone on the sidelines might consider now an appropriate time to strike. “Only a small number of companies can amass the capital to deliver semiconductors, which are increasingly central to people’s lives,” said Tom Russo, a partner at Gardner, Russo & Quinn in Lancaster, Pennsylvania, who is bullish on Berkshire Hathaway and TSM.  

U.S. investors have been cautious when betting on the Taiwan-based chipmaker as it would lose all Western contracts in the event of a Chinese takeover of the island. However, the company is working to reduce its geopolitical risk with a new $40 billion foundry in Arizona, expected to be operational by 2024. The investment has Washington’s support as it comes amid a U.S. push to boost domestic supplies of semiconductors and Congressional passage of the $52 billion CHIPS and Science Act. 

Taiwan Semi reported $1.79 per share earnings from $20.23 billion in revenue in the third quarter, surpassing consensus expectations of $1.41 EPS from revenue of $19.96. Management reiterated its outlook of Q4 revenue in the range of $19.9 billion to $20.7 billion. The gross profit margin is expected to be between 59.5% and 61.5%. The operating profit margin is expected to be between 49% and 51%.  

TSM has a 90% Buy rating from the 38 analysts offering recommendations and zero Sell ratings. Anyone on the sidelines may want to consider striking up a position in this stock ahead of the company’s earnings call, slated for Thursday, January 12th.  

U.S.-based Trulieve Cannabis (TCNNF) stands out as one of the few cannabis companies that have been able to turn a steady, meaningful profit, with four years of consistent quarterly profitability under its belt. That is, up until its most recent quarter, when the company reported a net loss on the bottom line of $22.5  million, compared to the net income of $40.9 million reported for the previous year’s quarter. However, much of the loss can be attributed to one-time charges related to Trulieve’s recent acquisition of Harvest & Recreation Health. The quarterly net loss came in at around $1.1 million without the one-time charges.  

While the company’s recent loss might be looked at as a step in the wrong direction, it’s common to see this following a significant acquisition. Trulieve’s cannabis revenue has been following a steady upward trajectory since well before the acquisition took place. During the second quarter, revenue increased by 49% year over year to $320.3 million. 

The company has been steadily expanding operations, nearly tripling in size over the past few years. Since June 2020, when it had just 52 dispensaries, all located in Florida, the company operates 177 market-leading dispensaries throughout 11 states. It has successfully done so to preserve its position as a major player in this increasingly competitive market.

Trulieve Cannabis garners a 100% Buy rating from the 18 analysts offering recommendations. A median price target of $28.71 represents a 169.62% upside. TCNNF is one of the best picks to profit from the cannabis opportunity. 

Three Stocks to Avoid For Now

Seeking out great stocks to buy is important, but many would say it’s even more essential to know which stocks to steer clear of. A losing stock can eat away at your precious long-term returns. So, determining which stocks to trim or eliminate is essential for proper portfolio maintenance.  

Even the best gardens need pruning, and our team has spotted a few stocks that seem like prime candidates for selling or avoiding. Continue reading to find out which three stocks our team is staying away from this week. 

With airline stocks currently trading at extremely low multiples, long-term-minded value seekers may be eyeing the group, wondering which ticker is the better buy. But some airlines are still drowning in debt from the pandemic. While several have had to cut routes and scale back on expansion plans as supply chain and labor constraints have delayed the production of new aircraft, airlines continue to struggle with labor shortages. The first name on our list of stocks to avoid is an air carrier that seems less equipped to handle what may be in the wings for the entire industry.  

Jet Blue Airways (JBLU) has not had an easy year amid rising fuel costs, supply chain disruptions, and inflationary pressure. Recent losses have been compounded by Hurricane Nicole, a rare November storm that made landfall on the Atlantic Coast of Florida, causing closures and evacuations throughout the state and leaving a wake of destruction in its path. As a result, JetBlue was forced to cancel and suspend flights and issue travel waivers for destinations in the storm’s path. Nicole negatively affected operations for several airlines, but of those impacted, JetBlue seems to be struggling the most to bounce back. 

With hurricane Nicole’s negative impact on operations, demand for the final month of the year has not been as strong as expected, according to the company’s management. As a result, the company revised its year-end and Q4 outlook. Management anticipates revenue per available seat mile for the fourth quarter of 2022 to be at the low end of its prior guided range of a 15-19% increase from the fourth quarter of 2019. JetBlue’s disappointing comments on air-travel demand resulted in the decline of shares of most airlines. The NYSE Airline index lost 5.77% over the past week, while JBLU sank nearly 8%. 

With airline stocks currently trading at extremely low multiples, value seekers may be eyeing the group, wondering which ticker is the better buy. Some airlines will be more suited to withstand a slowing economy and possible recession, while JetBlue does not seem well-equipped for further negative impact. Anyone considering JBLU at less than 8 times earnings would do better to consider a more stable name.   

 While the future remains bright for renewable energy, not all solar stocks are a buy. Provider of solar engineering and construction services, iSun Inc. (ISUN), has seen operating losses skyrocket alongside revenue increases in recent years.  

iSun reported third-quarter 2022 revenue of $19 million, representing a 185% increase over the same period in 2021. Alongside top-line growth over the past year, the company has reported $22 million in operating losses. Operating income in the third quarter was a loss of $4.9 million compared to a loss of $1.6 million over the same period in 2021. YTD’s operating income was a loss of $16.2 million compared to a loss of $7 million during the same period in 2021.

Given the company’s already high debt position after a series of acquisitions in 2021, the additional losses could force the company to raise equity in order to de-lever its balance sheet, which could mean further declines for iSun.  

The small, unprofitable solar company’s stock is down 80% over the past 12 months, but it’s far from a bargain considering the risk factor.  

There’s no question that electric vehicles are the future, but investors looking for bargains in the midst of the market meltdown would be wise to steer clear of third-party companies specializing in EV charging stations like Blink Charging (BLNK). It’s much too soon to predict winners in this cutthroat niche of the EV industry, mainly because it’s still unclear if third-party charging kiosks will ever be profitable.  

Analysts don’t see Blink becoming profitable before 2026. By then, the company will likely be looking at a much different landscape – a lot can change in three years. From the current vantage point, the near future looks murky for the entire EV industry, considering the massive layoffs that have taken place this year amid supply chain pressure and production restrictions in China.  

Blink Charging shares have fallen 76% since peaking in early 2021 and are 53% lower year-to-date, but the stock is still trading at 23 times revenues. For perspective, the price-to-sales ratio for the S&P 500 index as of December 1 was roughly 3. This was also way higher than what the ratio has been historically. The current consensus is to Hold Blink stock. We’ll stick to the sidelines on third-party EV charging companies until EV industry headwinds subside.  

Two Biotech Stocks to Buy in 2023 and One to Avoid

Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that could only have been imagined in the past.

This golden age is also presenting tremendous opportunities for investors. Biotech stocks offer the potential for huge gains. However, losing biotech stocks can rapidly eat away your precious long-term returns. So, determining which biotech stocks are best positioned and which to steer clear of is essential. 

This list will cover two biotech names that look like good options to move significantly higher in 2023 and one that seems too risky to get involved with.  

Drugmaker, Viatris’ (VTRS)  portfolio currently comprises more than one thousand approved molecules across a wide range of critical therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor, and Viagra. Its biosimilar portfolio includes pegfilgrastim, trastuzumab, and adalimumab biosimilars.

Viatris is profitable, but it is looking for more growth. The company reported revenue of $4.1 billion in the third quarter, down 10.1% year over year. Adjusted earnings came in at $0.87 per share, surpassing consensus estimates but down from $0.99 per share in the year-ago quarter. 

The company generated $144 million in revenues from products launched in 2022, primarily driven by lenalidomide, its myeloma treatment, its interchangeable insulin injectable Semglee, and its unbranded insulin pen in the United States. It is on track to achieve approximately $525 million in new product revenues in 2022, which is below expectations due to the timing of launches but with better-than-expected margins.

Viatris’ earnings are expected to contract by 4% in 2022, and the stock is down 17% over the past year. However, analysts, on average, expect Viatris to rise nearly 18% going forward, according to FactSet. The reason behind Wall Street’s optimism is changes to the company’s business plan that have already been set into motion. 

The company is trimming its less-profitable operations, including its biosimilars, women’s health division, and over-the-counter drugs. In its place, it is adding an ophthalmology franchise through the $750 million acquisitions of Oyster Point Pharma and Famy Life Sciences. The deal is expected to close in the first quarter of 2023. Management expects the acquisition to generate at least $1 billion in sales by 2028.

The company has a relatively high debt-to-equity ratio of nearly two, but it has the right idea by trimming its less-profitable operations and paying down its debt. Management sees revenues expanding at a CAGR of 3% between 2024 and 2028 and EPS expanding at a CAGR of around 15% over the same period. VTRS hopes to use the expanding revenue to reward its investors through steady dividend growth. Its current yield is 4.4%, and its payout ratio is very safe at 20%. Though it’s a speculative recommendation based on the success of the company’s business transition, the rewards could be handsome.

Global healthcare leader Eli Lilly And Company (LLY) has been creating high-quality medicines for over a century. The drug firm focuses on endocrinology, oncology, neuroscience, and immunology. Essential products include Trulicity, Jardiance, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Verzenio and Alimta for cancer.  

The mega-cap pharmaceutical giant’s pipeline is locked and loaded with promising advancements, which means plenty of upcoming potential opportunities for investors to benefit from. In the first half of 2022, Lilly received word that the FDA was fast-tracking its investigation of tirzepatide, a drug designed to treat adults who are overweight with weight-related comorbidities such as diabetes. Eli Lilly expects its rolling application to be completed by April 2023.

JPMorgan analyst Chris Schott recently summed up his bullish outlook on LLY. The analyst believes that Eli Lilly remains the best-positioned growth story in his coverage and one of his top picks following the stock’s pullback over the past month. The analyst sees a “significant opportunity” for Tirzepadite in type 2 diabetes and obesity, which in his view, “warrants increased attention.” Schott currently gives the stock an Overweight rating and a $400 price target.  

Lilly’s share price increased 40% in 2022 and seems likely to continue to gain steam into the new year. The stock sports a quarterly dividend of $1.13 per share or 1.24% annually. LLY’s dividend payout for the year is set for the low 40% range, which should allow for robust future dividend growth.

A strong pipeline and a stable dividend make Eli Lilly an attractive consideration. The pros on Wall Street also think so. Among 17 polled analysts, 14 say to Buy LLY, 2 call it a Hold, and only 1 rates the stock a Sell. A median 12-month price target of $400 represents a 10% increase from its current price.

Not every biotech stock is going to be a winner in 2023. COVID-19 vaccine winner Moderna (MRNA) is one name to avoid for now. If you had purchased MRNA shares before the pandemic in 2020, that investment would be worth around five times the initial purchase price today. The abundant cash flow generated from Moderna’s covid vaccine, Spikevax, helped finance share buybacks and grew its balance sheet in 2022. But with the worst of the pandemic in the rearview for most developed markets, sales have nowhere to go but lower.  

Heading into 2023, Moderna is still relying on its covid vaccine to bring in the lion’s share of its income. This year the company is expected to bring in between $18 and $19 billion in advanced purchase agreements for Spikevax amid increasing competition. Meanwhile, its cancer vaccine studies are still mid-stage, so it’s too early to assume they will get the nod from the U.S. Food and Drug Administration. Assuming they succeed in late-stage trials and receive FDA approval, sales are unlikely to trend higher again for at least the next three years.  

Generating its income from a single drug (Spikevax) is a risk no $70 billion company should take. With the worst of COVID-19 behind us, Moderna’s sales could plunge by 25% to 68% this year based on analyst expectations. The consensus of $8.74 billion represents a valuation of 9 times sales, which is quite pricey within the biotech space.

Three High-Yield Dividend Stocks for the New Year

Amid unrelenting inflation and a strong potential for a recession, volatility is widely expected to continue as we head into the new year, making the job of selecting stocks difficult. A logical move in times like these is dividend stocks, which pay you to hold them. Dividend-paying companies regularly reward investors directly with a portion of the cash flow. The most desirable dividend stocks have a history of raising payouts over time as the company’s profits grow.  

In this list, we’ll look at three yield-paying stocks that seem ripe for the picking as we head into the new year.  

Pioneer Natural Resources Company (PXD) has long viewed sustainability as a balance of economic growth, environmental stewardship, and social responsibility. Its emphasis is on developing natural resources that protect surrounding communities and preserve the environment.

In the wake of the pandemic, when energy prices were, cheap PXD struck an almost perfectly timed agreement to buy fellow Permian Basin producer Parsley Energy for $4.5 billion. If you’re wondering how PXD managed to finance that transaction, the answer lies in the fact that it was an all-stock deal that ensured Pioneer didn’t have a new giant debt load hanging over its head. The fact that Parsley operated primarily in the same region of West Texas, where Pioneer had both expertise and existing staff, has paid off over time.   

That deal was a coup for Pioneer shareholders, built on the fact it was large and well-capitalized at a time when stressed and debt-reliant shale plays were looking for a white knight. On top of that acquisition, PXD also boosted its dividend by 25% at the start of the year as further evidence of its strong balance sheet.

Investors can look forward to upcoming tailwinds, including Pioneer’s recently announced partnership with the world’s largest renewable energy producer, NextEraEnergy (NEE), to develop a 140-megawatt wind generation facility on Pioneer-owned land. The project will supply the company’s Permian Basin operations with low-cost, renewable power and is expected to be operational next year.  

In the third quarter, revenue was up 22% YOY to $6.09 billion, smashing the consensus estimate of 4.57 billion. The company reported earnings of $7.48 per share, beating consensus expectations of $7.27 per share. So far, in 2022, the company has rewarded its investors handsomely with $20.73 per share through its generous 10.78% cash dividend. Chief Executive Officer Scott D. Sheffield stated, Pioneer continues to execute on our investment framework that provides best-in-class capital returns to shareholders. This framework is expected to result in $7.5 billion of cash flow being returned to shareholders during 2022, including $26 per share in dividends and continued opportunistic share repurchases.”

Even after gaining 33% over the past year, Pioneer shares likely still have valuation upside in addition to their tremendous dividend income potential.   

Anyone who has kept tabs on the global supply chain and shipping saga that’s been unfolding since the outbreak of covid is probably familiar with Genco Shipping (GNK). The company owns a fleet of 44 ships it leases for dry bulk transportation of goods like grain, coal, and iron ore. The going rate to rent one of Genco’s ships is no less than $27,000 per day, which provides some solid cash flow that the company uses to reward its shareholders.  

Dry bulk shipping rates, along with GNK’s share price, have fallen in recent months. Still, as China recovers from recent lockdowns and seasonal demand is expected to be strong, it’s hard to see the pullback in share price as anything less than an opportunistic bargain. This is a very volatile sector, but it’s essential to the world’s supply chain. 

Although the company missed consensus EPS and revenue estimates in the third quarter, it remained consistent with its previously outlined value strategy. The company’s prudent cargo coverage in Q2 resulted in significant benchmark freight outperformance in Q3, allowing Genco to pass the savings onto its investors via a 56% quarterly dividend increase on a sequential basis. Over the last four quarters, the company has declared dividends of $2.74 per share, delivering on its commitment to return substantial capital to shareholders. GNK currently pays a 20% dividend yield.  

It should be no surprise that the defense giant Lockheed Martin (LMT) has outperformed the market this year. There are apparent geopolitical implications with the war in Ukraine. When Russia decided to invade its neighbor, both U.S. and European forces rushed in to help Ukraine. It may be some time before LMT stock pops again, as it did at the onset of Russia’s invasion of Ukraine. However, its order books are likely to improve due to rising defense budgets in the U.S. and abroad. Along with Lockheed providing support to Ukrainian resistance fighters, the looming uncertainties in Russia could lead to massive economic problems and gaps in power in former Soviet Union-controlled areas.

Given the recession-proof nature of defense contracting, Lockheed Martin should continue reporting positive results and rewarding shareholders through its quarterly 2.7% forward yield. In other words, even if the market dives again, LMT will likely stand firm. The company runs a P/E ratio of 24 times, below the sector median of 28.3 times. As well, LMT features excellent longer-term growth and profitability metrics.

Popular Posts

My Favorites

The Exit Strategy: Stocks Showing Critical Warning Signs

0
May 17, 2025 Every successful investor knows a painful truth: knowing when to sell is often more critical than knowing what to buy. While financial media...